Oxygen Therapy Equipment Market Analysis, Segments, Key Players, Drivers, Trends and Forecast

According to the new market research report "Oxygen Therapy Equipment Market by Product (Oxygen Source (Concentrator, Cylinder), Delivery Devices), Portability (Stationary, Portable), Application (COPD, Asthma, Cystic Fibrosis, Pneumonia), End User (Hospital, Home Care) - Global Forecast to 2022", published by MarketsandMarkets™, The oxygen therapy equipment market is expected to reach USD 4.01 Billion, at a CAGR of 8.7%

Factors driving the growth of this market are the increasing prevalence of respiratory disorders, rapid growth in the geriatric population, prevalence of tobacco smoking, preference towards home-based oxygen therapy, and technological advancements to develop novel products delivering oxygen therapy.

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=118828572

Oxygen source equipment is expected to dominate the market in 2017

On the basis of products, the oxygen therapy equipment market is segmented into oxygen source equipment and oxygen delivery devices. The oxygen source equipment segment is expected to dominate the global oxygen therapy equipment market in 2017. The increasing incidence of respiratory disorders and technological advancements to develop smaller, quieter and more effective equipment are key drivers increasing the demand for oxygen source equipment.

Browse and in-depth TOC on "Oxygen Therapy Equipment Market"

148 - Tables

46 - Figures

175 - Pages

Stationary oxygen therapy devices are estimated to command the largest market share in 2017

The oxygen therapy equipment market is segmented by portability into stationary devices and portable devices. In 2017, the stationary devices segment is expected to account for the largest share of the oxygen therapy equipment market, by portability. Severe complications in patients suffering from respiratory disorders and the increasing proportion of geriatric population across the globe are major drivers for the growth of this segment.

North America to account for the major market share in 2017

Based on region, the oxygen therapy equipment market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America is expected to dominate the oxygen therapy equipment market in 2017 on account of the increasing proportion of the geriatric population, rising number of hospitals, and increasing awareness regarding oxygen therapy.

Read a Press Release on “Oxygen Therapy Equipment Market”:

https://www.marketsandmarkets.com/PressReleases/oxygen-therapy-equipment.asp

Key players in the oxygen therapy equipment market include Philips Healthcare (Netherlands), Linde Healthcare (Germany), Chart Industries, Inc. (U.S.), Invacare Corporation (U.S.), Becton, Dickinson and Company (U.S.), Smiths Medical (U.S.), Drägerwerk AG & Co. KGaA (Germany), Teleflex Incorporated (U.S.), Fisher & Paykel Healthcare Corporation Limited (New Zealand), medicap homecare GmbH (Germany), GCE Holding AB (Sweden), Allied Healthcare Products Inc. (U.S.), Medicop D.O.O. (Slovenia), Andreas Fahl Medizintechnik-Vertriebs GmbH (Germany), and Respan Products Inc. (Canada).

Cell Lysis Market 2019 Dynamics Set For Rapid Growth and Trend

The Research Report Consist of 135 pages, which covers Global Cell Lysis Market overview, Major Key Players detailed Analysis, market opportunities, market risk, forecast for the next five years, major driving factors for the market as well as detailed analysis for CAGR, scope, research findings, leading key players marketing strategy to acquire major market in the form of revenue.

The Research report on Cell Lysis Market covers key statistics for the upcoming forecast year. This Research Report is a big source for the guidance to business leaders, strategy heads.

The major factor driving the growth of this Cell Lysis Market is increasing government funding for research, the high prevalence of diseases, expanding biotechnology and biopharmaceutical industries, and the growing focus on personalized medicine the consumables market includes reagents and kits, beads, and disposables. Reagents and kits are further classified into enzymes, detergent solutions, and other reagents and kits.

Download PDF (Cell Lysis Market):

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=260138321

Target Audience for the Research Study:

• Cell Lysis instrument manufacturers and suppliers
• Academic Research Institutes
• Biopharmaceutical and Biotechnology Companies
• Research and development (R&D) companies
• Business research and consulting service providers
• Medical research laboratories
• Academic medical centers and universities

This research report segments the Cell Lysis Market on basis of product, type of cell, end-users.

In the products market, the assay kits & reagents segment is expected to account for the largest share. This segment is also expected to grow at the highest CAGR during the forecast period due to the growth in the number of reagent rental agreements and the increasing prevalence of autoimmune diseases worldwide.

Cell Lysis Market Based on the type of cell;

The Market is segmented into mammalian cells, microbial cells, and other cells. The mammalian cells segment is expected to account for the largest share of the global Cell Lysis Market in 2016. A rising aging population and increasing need for the development of new cell therapies are the key factors propelling the growth of this market.

Cell Lysis Market Based on end-users;

End-users, included in the Market are research laboratories and institutes, biopharmaceutical and biotechnology companies, and others. The research laboratories and institutes segment are expected to account for the largest share of the global Cell Lysis Market in 2016. High incidence of diseases and research investments in life sciences is driving the growth of this market.

Cell Lysis Market Based on Region;

The Global Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the Cell Lysis Market during the forecast period. Growth in this regional segment is driven by factors such as an increase in the aging population and increasing government funding in North America.

Read More in Detailed (Cell Lysis Market):

https://www.marketsandmarkets.com/Market-Reports/cell-lysis-market-260138321.html

Single-cell Analysis Market Growth and key Industry Analysis and Forecasts

The growth in this Single-cell Analysis Market is mainly driven by the technological advancements in single-cell analysis products, increasing government funding for cell-based research, growing biotechnology and biopharmaceutical industries, wide applications of single-cell analysis in cancer research, a growing focus on personalized medicine, and increasing incidence and prevalence of chronic and infectious diseases.

Single-cell analysis market: The objectives for this study are as follows

• To define, describe, and forecast the market based on products, cell type, technique, application, end user, and region.
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
• To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the market
• To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of market segments with respect to four regions, namely, North America, Europe, Asia, and the Rest of the World (Row)

The research report segments the market into product, cell type, technique, application, end user, and regions.

Read a Press Release on "single cell analysis market"
https://www.marketsandmarkets.com/PressReleases/single-cell-analysis.asp

Single-cell Analysis Market Based on Product;

Based on the product, the market is segmented into consumables and instruments. In 2017, the consumables segment is expected to account for the largest share of the market. This segment is also expected to register the highest CAGR during the forecast period. The growth of this segment is attributed to the requirement of frequent and repeat purchase of these products as compared to instruments, which are considered as a one-time investment.

Single-cell Analysis Market Based on Cell Type;

by cell type is segmented into human, animal, and microbial cells. In 2017, the human cells segment is expected to account for the largest share of the market. The growing application areas of human stem cells and the rising incidence of diseases such as cancer are the major factors driving the growth of this segment.

Single-cell Analysis Market Based on Technique;

Based on the technique, the market is segmented into flow cytometry, NGS, PCR, microscopy, mass spectrometry, and other techniques (including single-molecule fluorescence in situ hybridization, micromanipulation, and automated capillary electrophoresis). In 2017, flow cytometry is expected to account for the largest share of the market. The large share of the flow cytometry segment can primarily be attributed to the wide usage of flow cytometry in single-cell analysis applications.

Know more about key industry players:

https://www.marketsandmarkets.com/ResearchInsight/single-cell-analysis-market.asp

Global Veterinary Chemistry Analyzer Market by End-User Industry and By Application and Forecast

The Growth of Veterinary Chemistry Analyzer Market is majorly attributed to factors such as growing livestock and companion animal population, rising animal healthcare expenditure, rising pet adoption, growing demand for animal-derived food products, raising awareness about zoonotic diseases, and an increasing number of veterinary practitioners across the globe.

Research Methodology Adopted by MarketsandMarkets™:

Top-down and bottom-up approaches were used to validate the size of the global veterinary chemistry analyzer market and estimate the size of various other dependent submarkets. This study estimates the market size for 2017 and projects its demand until 2022. The major players in the market were identified through secondary research and their market revenues were determined through primary and secondary research.

Secondary research included the study of the annual and financial reports of the top market players, whereas primary research included extensive interviews with the key opinion leaders such as CEOs, directors, and marketing executives. The percentage splits, shares, and breakdowns of the product markets were determined using secondary sources and verified through primary sources.

Download PDF (Veterinary Chemistry Analyzer):

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=48798056

The global veterinary chemistry analyzer market is segmented based on product, application, animal type, and region.

Veterinary Chemistry Analyzer Market Based on Product;

Based on the product, this market is segmented into instruments and consumables (panels, kits, test strips, and reagents). In 2016, the consumables segment accounted for the largest share of the global veterinary chemistry analyzer market. It is expected to register the highest growth during the forecast period. The high growth of this segment is mainly attributed to the increased adoption of the pre-loaded multiple reagent panels and pre-loaded single slide reagent panels by the end users.

Veterinary Chemistry Analyzer Market Based on Application;

Based on application, the market is categorized into blood chemistry analysis, urinalysis, glucose monitoring, and blood gas-electrolyte analysis. The blood chemistry analysis segment accounted for the largest share in 2016, while the glucose-monitoring segment is expected to witness the highest growth during the forecast period. The veterinary chemistry analyzer market is further segmented,

Veterinary Chemistry Analyzer Market Based on animal type;

based on animal type, into companion animals and livestock. In 2016, the companion animal segment accounted for the largest share of the market. This segment is also expected to register the highest growth during the forecast period.

Read More in Detailed (Veterinary Chemistry Analyzer):

https://www.marketsandmarkets.com/Market-Reports/veterinary-chemistry-analyzer-market-48798056.html

Interventional Oncology Market 2019 – Global Industry Size, Share, Analysis, Trend & Future Strategic Planning

The Global Interventional Oncology Market is anticipated to grow at a steady rate during the forecast period. The growth of the market is expected to be driven by major factors such as increasing acceptance and demand for minimally invasive cancer surgeries, technological advancements in the field of interventional oncology, and increasing prevalence of cancer cases across the globe.

Moreover, ongoing modernization of healthcare infrastructure across emerging countries and growing research activities supported by increased public and private funding are expected to offer high growth opportunities for players active in the Interventional Oncology Market.

Download PDF (Interventional Oncology):

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203687164

However, the dearth of well-trained oncologists & radiologists across major countries is expected to restrain the optimal demand growth of this market during the forecast period.

Interventional Oncology Market segmentation:

· based on technology.

· based on application.

· based on end users.

· based on regions.

The Major Players Operating in the Interventional Oncology Market:

Medtronic plc; Boston Scientific Corporation; Medtronic, Plc; Varian Medical Systems, Inc.; Elekta AB are some of the key players present in global Interventional Oncology Market. Over the past three years, these companies adopted new product launches and enhancements, collaborations, agreements, partnerships, and geographical expansions as their key business strategies to ensure their growth in this market.

Geographical Detailed Analysis for Interventional Oncology Market:

• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Read More in Detailed (Interventional Oncology):

https://www.marketsandmarkets.com/Market-Reports/interventional-oncology-market-203687164.html

Global Prenatal Management Market Size, Status, Overview and Future Forecast

Major factors driving the growth of this Prenatal Management Market include increasing prevalence of birth defects, rising government initiatives for improving maternal/fetal health across the globe, increasing company investments in the development of prenatal management systems, shortage of nursing staff and doctors, and technological advancements.

However, the high cost of systems and lack of skilled professionals are expected to restrain the growth of this market. Emerging economies and cloud-based models present an array of opportunities for the growth of this market.

Download PDF (Prenatal Management): https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158399748

Prenatal Management Market segmentation:

· based on stages

· based on birth defects

· based on component,

· based on delivery mode,

· based on end user

· based on regions.

The Major Players Operating in the Prenatal Management Market:

Prominent players in the prenatal management market are Allscripts Healthcare Solutions (U.S.), Biomedia Holdings Pte Ltd (Singapore), Cerner Corporation (U.S.), Clinical Computer Systems Inc. (U.S.), GE Healthcare (U.K.), Mckesson Corporation (U.S.), Perigen (U.S.), Perkin Elmer, Inc. (U.S.), Philips Healthcare (Netherlands), and Siemens Healthcare (Germany).

Prenatal Management Market, By Birth Defects

• Down syndrome
• Trisomy 18
• Neural Tube Defects
• Abdominal Wall Defects
• Smith-Lemli-Opitz syndrome

Geographical Detailed Analysis for Prenatal Management Market:

North America dominates the prenatal management market, with the U.S. accounting for a major market share. However, Asia is poised to grow at the highest CAGR during the forecast period, owing to a rising focus of major market players and increasing the birth rate in this region.

Read More in Detailed (Prenatal Management):

https://www.marketsandmarkets.com/Market-Reports/prenatal-management-market-158399748.html

Global Cell Signaling Market by End-User Industry and By Application and Forecast

The Research Report Consist 157 market data tables and 76 figures spread through 212 pages, which covers Global Cell Signaling Market overview, Major Key Players detailed Analysis, market opportunities, market risk, forecast for the next five years, major driving factors for the market as well as detailed analysis for CAGR, scope, research findings, leading key players marketing strategy to acquire major market in the form of revenue.

Also, the Research report on Cell Signaling Market covers key statistics for the upcoming forecast year. This Research Report is a big source for the guidance to business leaders, strategy heads.

Download PDF (Cell Signaling):https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=80206120

The Global Cell Signaling Market is expected to reach $ 3.51 billion by 2022, at a CAGR of 6.8%

Cell Signaling Market based on pathway:

The market is segmented into AMP-activated protein kinase (AMPK), Akt, ErbB/HER, Hedgehog (Hh), NF-êB, Janus kinase, and signal transducer and activator of transcription (JAK/STAT), Notch, and other signaling pathways. The Akt pathway segment is estimated to account for the largest share of the market

Cell Signaling Market based on signaling type:

The market is segmented into paracrine, endocrine, autocrine, juxtacrine, and other signaling types (intracrine and neuronal signaling). The endocrine segment is estimated to account for the largest share of the market.

Cell Signaling Market based on technology:

The market is segmented into enzyme-linked immunosorbent assay (ELISA), immunohistochemistry (IHC), microscopy, flow cytometry, western blotting, mass spectrometry, and other technologies (immunofluorescence and immunoprecipitation). The microscopy segment is estimated to account for the largest share

Cell Signaling Market based on application:

The market is segmented into research applications (cancer research, immunology research, stem cells research, and other research applications) and medical applications. The Cell Signaling Market research applications segment is estimated to account for the largest share of the market

The Major Players Operating in the Cell Signaling Market:

The key players in the market include Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson and Company (U.S.), Beckman Coulter, Inc. (U.S.) (a subsidiary of Danaher Corporation), Bio-Rad Laboratories, Inc. (U.S.), PerkinElmer Inc. (U.S.), Cell Biolabs, Inc. (U.S.), Cisbio Bioassays (France), Rockland Immunochemicals Inc. (U.S.), BioVision, Inc. (U.S.), Tonbo Biosciences (U.S.)

Read More in Detailed (Cell Signaling):

https://www.marketsandmarkets.com/Market-Reports/cell-signaling-market-80206120.html

Opioids Market Research Report 2019 By Key players & Growth Drivers

Opioids Market is witnessing growth due to the increasing prevalence of orthopedic diseases and chronic pain, rising focus on abuse-deterrent formulation (ADF), rising palliative care facilities, and inclination toward extended release formulations from the immediate release of Opioids.

However, factors such as prescription drug abuse, and legalization of cannabis as an alternative to Opioids may hinder the growth of the market in the coming years. This report is a comprehensive study of current trends in the Opioids Market, industry growth drivers, and restraints.

Opioids are a group of narcotic pain-relieving drug which acts by interacting with opioid receptors in cells. Opioids can be made from the poppy plant such as morphine or synthesized in a laboratory such as fentanyl. It is used as anesthesia, cough suppressant, diarrhea suppressant and for the management of pain arising from various disease.

Download PDF(Opioids):

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=196253848

Opioids Market segmentation:

· based on a product.

· based on receptor binding.

· based on application.

· based on regions.

Opioids Market Product And receptor binding:

Based on the product, the market is divided into morphine, codeine, fentanyl, meperidine, methadone, and others. Based on the receptor binding, the market is segmented into strong agonist, and mild to moderate agonist.

Opioids Market by Application:

· Pain Management

1. Cancer Pain

2. Neuropathic Pain

3. Osteoarthritis Pain

· Cough Suppression

· Diarrhea Suppression

The Major Players Operating in the Opioids Market:

The major players in the Infant nutrition market are Purdue Pharma (US), Sanofi (France), Pfizer (US), Janssen Pharmaceuticals (Belgium), Endo Pharmaceuticals, Inc (US), Actavis Plc (US), Egalet (US), Sun Pharmaceuticals (India), and Boehringer Ingelheim GmbH (Germany).

Geographical Detailed Analysis for Opioids Market:

These markets are given analysis at the regional level to provide exhaustive Opioids Market analysis for the years 2016, 2017, 2018, and forecast to 2023.

The Opioids Market is comprehensively analyzed at a granular level by region (North America, Europe, Asia, and Rest of the World) to provide in-depth information on the global scenario.

Read More in Detailed (Opioids):

https://www.marketsandmarkets.com/Market-Reports/opioids-market-196253848.html